1 |
Wu H, Qian D, Bai X, Sun S. Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/2515525] [Reference Citation Analysis]
|
2 |
Qi X, Guo J, Chen G, Fang C, Hu L, Li J, Zhang C. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Journal of Immunology Research 2022;2022:1-32. [DOI: 10.1155/2022/3393027] [Reference Citation Analysis]
|
3 |
Wang M, Zhang Y, Chang W, Zhang L, Syrigos KN, Li P. Noncoding RNA-mediated regulation of pyroptotic cell death in cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1015587] [Reference Citation Analysis]
|
4 |
Guo Y, Pan S, Ke Y, Pan J, Li Y, Ma H. Seven Fatty Acid Metabolism-Related Genes as Potential Biomarkers for Predicting the Prognosis and Immunotherapy Responses in Patients with Esophageal Cancer. Vaccines (Basel) 2022;10:1721. [PMID: 36298586 DOI: 10.3390/vaccines10101721] [Reference Citation Analysis]
|
5 |
Xiao J, Yuan W, Zhu X, Yan Y, Li W, Wu F, Mao B, Zhang J, Du Y, Zhu S, Wang B. Prognostic Signature of Pyroptosis-Related LncRNA Correlates with Clinical and Immunological Characteristics of Hepatocellular Carcinoma.. [DOI: 10.21203/rs.3.rs-2078140/v1] [Reference Citation Analysis]
|
6 |
Wang W, Ye Y, Zhang X, Ye X, Liu C, Bao L. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma. Front Mol Biosci 2022;9:937979. [DOI: 10.3389/fmolb.2022.937979] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
7 |
Yang Y, Shi L, Zhang J, Zheng Y, Wu G, Sun J, Liu M, Chen Z, Wang Y, Ji R, Guo Q, Zhou Y. A Novel Matrisomal-Related LncRNA Signature Associated With Survival Outcome and Immune Evasion in Patients With Gastric Cancer. Front Oncol 2022;12:926404. [DOI: 10.3389/fonc.2022.926404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|